Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Amyloid, Tau, and Neurodegeneration Biomarkers and Prediction of Clinical Onset, Cognitive Decline, and Dementia Diagnosis

NCT06547099 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06547099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06547099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Amyloid, Tau, and Neurodegeneration Biomarkers and Prediction of Clinical Onset, Cognitive Decline, and Dementia Diagnosis
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Recruiting
Start date
August 14, 2024
Completion date
December 31, 2028
Enrollment
1,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, mild cognitive impairment